ReviewInternational journal of molecular sciences2023

The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases.

Xuan-Bing Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.